Oxycontin and Central nervous system lesion - a phase IV clinical study of FDA data

Summary:

Central nervous system lesion is reported as a side effect among people who take Oxycontin (oxycodone hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years also take Zometa, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Central nervous system lesion when taking Oxycontin. It is created by eHealthMe based on reports of 210,595 people who have side effects when taking Oxycontin from the FDA, and is updated regularly.

What is Oxycontin?

Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.

What is Central nervous system lesion?

Central nervous system lesion (an abnormality in tissue of brain or spinal cord) is found to be associated with 779 drugs and 824 conditions by eHealthMe. Check the latest studies of Central nervous system lesion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

210,595 people reported to have side effects when taking Oxycontin.
Among them, 81 people (0.04%) have Central nervous system lesion.

Could Oxycontin cause Central nervous system lesion?

Among these 81 people:

How long have people been on Oxycontin when they have Central nervous system lesion? *

What is the gender of people who have Central nervous system lesion when taking Oxycontin? *

female: 66.25 %
male: 33.75 %

What is the age of people who have Central nervous system lesion when taking Oxycontin? *

What are other drugs people take besides Oxycontin? *

What are other side effects people have besides Central nervous system lesion? *

Stress And Anxiety: 49 people, 60.49%
Osteonecrosis Of Jaw (death of bone of jaw): 39 people, 48.15%
Weakness: 34 people, 41.98%
General Physical Health Deterioration (weak health status): 33 people, 40.74%
Fall: 32 people, 39.51%
Metastases To Bone (cancer spreads to bone): 31 people, 38.27%
Fatigue (feeling of tiredness): 29 people, 35.80%
Headache (pain in head): 28 people, 34.57%
Nausea (feeling of having an urge to vomit): 27 people, 33.33%
Depression: 26 people, 32.10%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 18 people, 22.22%
Multiple Myeloma (cancer of the plasma cells): 9 people, 11.11%
Breast Cancer Metastatic: 6 people, 7.41%
Anaemia (lack of blood): 5 people, 6.17%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 5 people, 6.17%
Joint Pain: 4 people, 4.94%
Depression: 4 people, 4.94%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 3.70%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 3.70%
Insomnia (sleeplessness): 3 people, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycontin and have Central nervous system lesion?

- Check whether Central nervous system lesion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxycontin:

Oxycontin (212,533 reports)

Browse all side effects of Oxycontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Central nervous system lesion:

Central nervous system lesion (779 drugs)

Browse all the conditions that are associated with Central nervous system lesion:

Central nervous system lesion (824 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Oxycontin) and Oxycontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.